Citadel Advisors’s Alzamend Neuro ALZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,404
| Closed | -$35.5K | – | 5902 |
|
|
2024
Q4 | $35.5K | Buy |
+3,404
| New | +$35.5K | ﹤0.01% | 5544 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 5758 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 5883 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6031 |
|
|
2022
Q3 | – | Sell |
-75
| Closed | -$88K | – | 5831 |
|
|
2022
Q2 | $88K | Buy |
+75
| New | +$88K | ﹤0.01% | 5338 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6288 |
|
|
2021
Q4 | – | Sell |
-34
| Closed | -$139K | – | 6399 |
|
|
2021
Q3 | $139K | Buy |
+34
| New | +$139K | ﹤0.01% | 5645 |
|